Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population

M. C.T. van Zeijl; M. W.J.M. Wouters; A. J. van den Eertwegh; M. J. Aarts; A. C.J. van Akkooi; F. W.P.J. van den Berkmortel; M. G. Franken; J. W.B. de Groot; K. H. Herbschleb; J. J.M. van der Hoeven; G. A.P. Hospers; E. Kapiteijn; D. Piersma; R. S. van Rijn; K. P.M. Suijkerbuijk; A. J. Ten Tije; A. A.M. Van der Veldt; G. Vreugdenhil; J. B.A.G. Haanen

doi:https://doi.org/10.1093/annonc/mdy289.032

Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population

M. C.T. van Zeijl, M. W.J.M. Wouters, A. J. van den Eertwegh, M. J. Aarts, A. C.J. van Akkooi, F. W.P.J. van den Berkmortel, M. G. Franken, J. W.B. de Groot, K. H. Herbschleb, J. J.M. van der Hoeven, G. A.P. Hospers, E. Kapiteijn, D. Piersma, R. S. van Rijn, K. P.M. Suijkerbuijk, A. J. Ten Tije, A. A.M. Van der Veldt, G. Vreugdenhil, J. B.A.G. Haanen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii455
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy289.032
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy289.032

Cite this

van Zeijl, M. C. T., Wouters, M. W. J. M., van den Eertwegh, A. J., Aarts, M. J., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., Franken, M. G., de Groot, J. W. B., Herbschleb, K. H., van der Hoeven, J. J. M., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Ten Tije, A. J., Van der Veldt, A. A. M., Vreugdenhil, G., & Haanen, J. B. A. G. (2018). Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii455. https://doi.org/10.1093/annonc/mdy289.032

@article{976ccc7a5a384e50bf292fb852680fc9,

title = "Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population",

author = "{van Zeijl}, {M. C.T.} and Wouters, {M. W.J.M.} and {van den Eertwegh}, {A. J.} and Aarts, {M. J.} and {van Akkooi}, {A. C.J.} and {van den Berkmortel}, {F. W.P.J.} and Franken, {M. G.} and {de Groot}, {J. W.B.} and Herbschleb, {K. H.} and {van der Hoeven}, {J. J.M.} and Hospers, {G. A.P.} and E. Kapiteijn and D. Piersma and {van Rijn}, {R. S.} and Suijkerbuijk, {K. P.M.} and {Ten Tije}, {A. J.} and {Van der Veldt}, {A. A.M.} and G. Vreugdenhil and Haanen, {J. B.A.G.}",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy289.032",

language = "English",

volume = "29",

pages = "viii455",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

van Zeijl, MCT, Wouters, MWJM, van den Eertwegh, AJ, Aarts, MJ, van Akkooi, ACJ, van den Berkmortel, FWPJ, Franken, MG, de Groot, JWB, Herbschleb, KH, van der Hoeven, JJM, Hospers, GAP, Kapiteijn, E, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, Ten Tije, AJ, Van der Veldt, AAM, Vreugdenhil, G & Haanen, JBAG 2018, 'Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii455. https://doi.org/10.1093/annonc/mdy289.032

TY - JOUR

T1 - Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population

AU - van Zeijl, M. C.T.

AU - Wouters, M. W.J.M.

AU - van den Eertwegh, A. J.

AU - Aarts, M. J.

AU - van Akkooi, A. C.J.

AU - van den Berkmortel, F. W.P.J.

AU - Franken, M. G.

AU - de Groot, J. W.B.

AU - Herbschleb, K. H.

AU - van der Hoeven, J. J.M.

AU - Hospers, G. A.P.

AU - Kapiteijn, E.

AU - Piersma, D.

AU - van Rijn, R. S.

AU - Suijkerbuijk, K. P.M.

AU - Ten Tije, A. J.

AU - Van der Veldt, A. A.M.

AU - Vreugdenhil, G.

AU - Haanen, J. B.A.G.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081532873&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy289.032

DO - https://doi.org/10.1093/annonc/mdy289.032

M3 - Article

C2 - 32137164

SN - 0923-7534

VL - 29

SP - viii455

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population

Access to Document

Other files and links

Cite this